CytRx Corp. buy melinda
Start price
13.06.17
/
50%
€3.13
Target price
22.06.17
€3.79
Performance (%)
21.80%
End price
22.06.17
€3.82
Summary
This prediction ended on 22.06.17 with a price of €3.82. The prediction had a final performance of 21.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | 2,59 % | 2,47 % | 8,84 % | 55,55 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % | 24,93 % | 73,04 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % | 47,39 % | 63,78 % |
| iShares S&P 500 | -0,37 % | -1,22 % | 21,67 % | 61,03 % |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
